|
|
210 Welsh Pool Road
Exton, PA 19341 USA
phone:(610) 423-6100
fax:
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.morphotek.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Antibodies for cancer, neovascular, inflammatory and infectious diseases. |
|
| Management |
| Nicholas Nicolaides, Ph.D., President, Chief Executive Officer; Philip Sass, Ph.D., Executive Vice President, Chief Operating Officer; Rodney Dausch, Vice President of Finance and Chief Financial Officer; Robert Radie, Chief Business Officer; Martin Phillips, M.D., Senior Vice President, Clinical Development; Luigi Grasso, Ph.D., Senior Vice President, Research & Development |
| |
|
|
| |
|
| Keywords |
| therapeutic antibodies, cancer, neovascular, inflammatory, infectious diseases, InfectiousDisease |
|
|
|
| Description |
|
Morphotek is a biotechnology company focused on the development of optimized therapeutic antibodies for the treatment of cancer, neovascular, inflammatory and infectious diseases. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members